Literature DB >> 2688099

Development of hirudin as an antithrombotic agent.

F Markwardt1.   

Abstract

Mesh:

Substances:

Year:  1989        PMID: 2688099     DOI: 10.1055/s-2007-1002719

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


× No keyword cloud information.
  15 in total

Review 1.  Management of patients with heparin-induced thrombocytopenia: focus on recombinant hirudin.

Authors:  N Lubenow; A Greinacher
Journal:  J Thromb Thrombolysis       Date:  2000-11       Impact factor: 2.300

Review 2.  Hirudin, a new therapeutic tool?

Authors:  J Bichler; H Fritz
Journal:  Ann Hematol       Date:  1991-08       Impact factor: 3.673

3.  Catabolism of hirudin and thrombin-hirudin complexes in the rat.

Authors:  J Bichler; J W Baynes; S R Thorpe
Journal:  Biochem J       Date:  1993-12-15       Impact factor: 3.857

Review 4.  Cardiovascular therapies in the 1990s. An overview.

Authors:  R C Becker; J M Gore
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

5.  Synthesis, structure, and structure-activity relationships of divalent thrombin inhibitors containing an alpha-keto-amide transition-state mimetic.

Authors:  R Krishnan; A Tulinsky; G P Vlasuk; D Pearson; P Vallar; P Bergum; T K Brunck; W C Ripka
Journal:  Protein Sci       Date:  1996-03       Impact factor: 6.725

Review 6.  Pharmacological properties of hirudin and its derivatives. Potential clinical advantages over heparin.

Authors:  M Monreal; J Costa; P Salva
Journal:  Drugs Aging       Date:  1996-03       Impact factor: 3.923

7.  Combination of a direct thrombin inhibitor and a platelet glycoprotein IIb/IIIa blocking peptide facilitates and maintains reperfusion of platelet-rich thrombus with alteplase.

Authors:  M S Sabatine; T M Tu; I K Jang
Journal:  J Thromb Thrombolysis       Date:  2000-10       Impact factor: 2.300

8.  Thrombin perturbs neurite outgrowth and induces apoptotic cell death in enriched chick spinal motoneuron cultures through caspase activation.

Authors:  V L Turgeon; E D Lloyd; S Wang; B W Festoff; L J Houenou
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

Review 9.  Thrombin inhibitors from different animals.

Authors:  A M Tanaka-Azevedo; K Morais-Zani; R J S Torquato; A S Tanaka
Journal:  J Biomed Biotechnol       Date:  2010-10-04

10.  Structural differences in active site-labeled thrombin complexes with hirudin isoinhibitors.

Authors:  J K Rowand; L J Berliner
Journal:  J Protein Chem       Date:  1992-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.